Welcome!

Oracle Authors: RealWire News Distribution, PR.com Newswire, Mark O'Neill

News Feed Item

XebiaLabs Reports Triple-Digit Growth in 2012

BOSTON, MA -- (Marketwire) -- 01/22/13 -- XebiaLabs, the leading provider of enterprise-class Application Release Automation (www.xebialabs.com) for the continuous delivery of enterprise software, today announced a record year of growth for 2012, citing demand in enterprise license sales for its flagship product Deployit, an application designed to replace the vast amount of scripting, time and resources required for provisioning infrastructure and deploying applications.

Extending its record of profitable growth, XebiaLabs posted record gains last year with revenue growth increasing by triple digits led in large part by winning new customers such as RBC Investor Services, 3M, Pitney Bowes, Xerox, IF, Societe Generale, and Rabobank.

"RBC Investor Services decided to implement XebiaLab's Application Release Automation to help reduce costs and save time," said Didier Baczynski, Senior Solution Architect, RBC Investor Services. "With Deployit, we reduced our deployment times from days to minutes. The deployment process is now a repeatable and predictable process rather than a unique journey relying on a 'hero' to make it happen."

According to a Gartner report by Ronni J. Colville, intelligent Application Release Automation tools help to minimize the risk of human error and add reliability. They also provide transparency for all of the stakeholders involved and, more importantly, limit downtime and ensure faster delivery to the end user.

"XebiaLabs is excited that global enterprises are choosing Deployit because it is the most scalable deployment automation solution on the market and the right fit for large enterprise deployments," said Coert Baart, CEO, XebiaLabs. "We are proud that these organizations are seeing an almost immediate reduction in application release times, lower overall IT expense and a fast return on investment."

In addition to a strong financial performance, XebiaLabs also completed a number of strategic initiatives to position it for even stronger growth in 2013. These include:

  • Relocating North American headquarters to accommodate expansion;
  • Expanding the XebiaLabs team in the U.S., Netherlands, France and India;
  • Launching of Deployit 3.8, a powerful yet easy to implement Application Release Automation solution that helps organizations automate and accelerate the deployment process resulting in increased productivity and saved OPEX.g3:

Most recently, the company announced a partnership with AMIS, an Information Systems firm specializing in Oracle consulting services.

Watch a 2-minute video of Deployit at: http://youtu.be/vNPQb8LkBWI

About XebiaLabs
XebiaLabs is the leading provider of enterprise-class application release automation solutions. XebiaLabs' flagship product, Deployit, automates Java EE deployments in an enterprise environment, allowing organizations to manage any IT environment by predictably executing and automating their Java application deployments. Deployit has 'out of the box' content for all major middleware stacks such as WebSphere, Microsoft .Net, WebLogic, JBoss, Tomcat and cloud environments like VMware, Red Hat and IBM but also with Built and Provisioning tools like Maven, Jenkings, Hudson, Bamboo, Puppet and Chef. XebiaLabs was founded in 2008, and currently serves various customers in 15 countries around the world. Headquartered in the United States, XebiaLabs is an international company with development and sales offices in France, Germany, Netherlands and India. In other countries, XebiaLabs works through a network of local representatives. For more information, please visit www.xebialabs.com.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Press Contact
Heather Sill-Moses
VP of Marketing
XebiaLabs
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.